NRX Pharmaceuticals, Inc. | ||||
NCM : NRXP || Location: United States | ||||
$0.47-0.06 (-10.94%) |
2.54 M | 0.42 - 0.54 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 3.714 M |
Feb. 29, 2024 | 2.714 M |
Feb. 15, 2024 | 3.868 M |
Jan. 31, 2024 | 2.874 M |
Jan. 12, 2024 | 2.921 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
09/30/2023 | -0.12 | -0.07 | 39.45% |
06/30/2023 | -0.14 | -0.12 | 13.92% |
03/31/2023 | -0.14 | -0.16 | -12.04% |
12/31/2022 | -0.15 | -0.16 | -8.18% |
09/30/2022 | -0.14 | -0.14 | 0.00% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 92.426M | Shares Float | 57.547M |
Short Float | 3.714M | Market Cap | 43.44M |
Institution ownership | 4.49% | Insider ownership | 31.108% |
Earnings Date | 05/14/2024 AMC | Cash Per Share | ? |
Trailing EPS | -0.50 | Forward EPS | -0.26 |